Doug has worked on a variety of initiatives for pharmaceutical and medical technology companies, including marketing strategy, pricing strategy, pricing research, management/analysis of forecasts, market assessments, and product acquisition assessments. His recent research and consulting work has included orphan drug pricing and perceptions of off-label prescribing. Prior to joining MME, he served as Vice President of Marketing for a medical device firm. He has been active at the national level with multiple pharmacy associations. He received a PharmD and a PhD in pharmaceutical marketing from the University of Mississippi. He currently holds an adjunct appointment as Assistant Professor at the University of Mississippi School of Pharmacy.